The University Medical Center (UMC) in Utrecht, the Netherlands, was a founding member of the consortium and the first cancer center to have an experimental MR-linac system installed for proof-of-principle testing. Mid-2016, the UMC installed its third MR-linac system - to be used for further non-clinical studies, and perhaps ultimately for clinical treatment.
By August 2016, four consortium members had completed or initiated installation of an MR-linac system:
- UMC Utrecht (2009, 2014, 2016)
- The University of Texas MD Anderson Cancer Center (Houston, US; 2015)
- The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (Amsterdam, the Netherlands; 2016)
- The Institute of Cancer Research, working with its clinical partner The Royal Marsden NHS Foundation Trust (London, UK; 2016).
Plans are underway to install MR-linac systems for evaluation at the remaining consortium members by the end of 2016: Sunnybrook Health Sciences Centre (Toronto, Canada), Froedtert & the Medical College of Wisconsin Froedtert Hospital (Milwaukee, US) and the Christie NHS Foundation Trust (Manchester, UK).